newsfilter
← Latest News
GlobeNewswire·

Larimar Therapeutics to Participate in Upcoming Investor Conferences

BALA CYNWYD, Pa., Aug. 27, 2024 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (NASDAQ:LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced